The Dialysis AI Humanoid Robotic Staffing project tackles the nephrology professional shortage through an AI-driven staffing platform, patient-provider matching app, and humanoid robots. With a revenue-generating platform already operational and patent-pending AI and robotic solutions in development, it aims to optimize dialysis care delivery and staffing efficiency.
For over a decade, nephrology nurses, doctors, and technicians, including those with dialysis expertise, have been in short supply in the United States and countries with populated retirees.
Join our active discord community to connect with researchers, patients, and supporters working together to advance the future of kidney health.
The KLF15 Agonist Phase I project targets albuminuria in chronic kidney disease, offering a potentially safer and more effective alternative to glucocorticoid therapy for conditions like FSGS and MCD. With promising efficacy and reduced toxicity, this novel approach is progressing towards patent licensing and IND roadmap development, aiming for accelerated FDA approval.
View project
Smartphone-based Facial remote patient management (RPM) AI, providing an affordable alternative to costly monitoring devices. FDA-cleared and patent-protected, it targets conditions like hypertension and CKD. Ready for deployment, it aims to revolutionize personalized medicine, beginning with mental health.
View project
CareYield leverages blockchain, AI, and community to tokenize healthcare assets, creating a liquid marketplace. It aims to accelerate innovation, improve outcomes, and reduce costs, targeting crypto investors while maintaining regulatory compliance.
View project
KidneyDAO's DeIPA is a revolutionary model that demonstrates the potential of CareYield's platform. By leveraging blockchain technology, artificial intelligence, and tokenization, DeIPA has addressed the limitations of traditional IPAs, unlocking new opportunities for growth, efficiency, and patient care.
View project
Intel MedPatch AI tackles medication non-compliance through automated lab testing and microneedle drug delivery. This system aims to reduce healthcare costs and medication errors, especially for elderly and rural patients. With patents for CKD and CHF, an obesity management grant, and potential Epogen partnership, it's progressing towards wider application.
View project
Learn more about how we can help accelerate your research.
Everything you need to know about the governance token that powers our community.
